Literature DB >> 24659250

Serum sialic acids levels according to the severity of liver cirrhosis.

Lech Chrostek1, Lukasz Supronowicz, Anatol Panasiuk, Bogdan Cylwik, Ewa Gruszewska, Maciej Szmitkowski.   

Abstract

BACKGROUND: The sialylation of serum proteins and lipids changes in liver diseases of different etiologies and could change the total sialic acid (TSA), lipid-bound SA (LSA), and free SA (FSA) levels in the sera. However, little is known of the relationship of serum SAs concentrations and the severity of liver disease. Therefore, the aim of this study was to investigate the SAs concentrations (TSA, LSA, and FSA) in liver cirrhosis in relation with the severity of liver disease.
METHODS: Tested group consisted of 91 consecutive patients suffering from liver cirrhosis. For each patient, the Child-Pugh score was calculated. TSA and LSA were determined by the enzymatic method on microplate reader, and FSA using the thiobarbituric method.
RESULTS: Among the SA forms, only the serum FSA level in liver cirrhosis appears to be different according to the severity of liver damage evaluated by the Child-Pugh score. It was the highest in score C, and was higher than that in scores B and A. The elevated levels of FSA significantly positively correlated with the Child-Pugh score.
CONCLUSION: In conclusion, the sialylation of serum proteins and lipids changes in liver cirrhosis, but only the serum concentrations of FSA are stage-related and reflect the severity of liver disease.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  severity of liver diseases; sialic acid; sialylation

Mesh:

Substances:

Year:  2014        PMID: 24659250      PMCID: PMC6807614          DOI: 10.1002/jcla.21711

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  13 in total

1.  Stress causes tissue-specific changes in the sialyltransferase activity.

Authors:  Sanja Dabelic; Mirna Flögel; Gordana Maravić; Gordan Lauc
Journal:  Z Naturforsch C J Biosci       Date:  2004 Mar-Apr

Review 2.  Measurement of sialic acid in serum and urine: clinical applications and limitations.

Authors:  P J Waters; E Lewry; C A Pennock
Journal:  Ann Clin Biochem       Date:  1992-11       Impact factor: 2.057

Review 3.  Alteration of protein glycosylation in liver diseases.

Authors:  Bram Blomme; Christophe Van Steenkiste; Nico Callewaert; Hans Van Vlierberghe
Journal:  J Hepatol       Date:  2008-12-27       Impact factor: 25.083

4.  Serum total and free sialic acid in patients with chronic liver disease.

Authors:  Bogdan Cylwik; Lech Chrostek; Anatol Panasiuk; Maciej Szmitkowski
Journal:  Clin Chem Lab Med       Date:  2010       Impact factor: 3.694

5.  [Serum sialic acid levels in liver cirrhosis and liver cancer (author's transl)].

Authors:  S Matsuzaki; M Itakura; K Iwamura; H Kamiguchi
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1981-12-01

6.  Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins.

Authors:  H J Senn; M Orth; E Fitzke; H Wieland; W Gerok
Journal:  Eur J Biochem       Date:  1989-05-15

7.  Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Application to sialic acid assay in analytical de-O-acetylation.

Authors:  L Skoza; S Mohos
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

8.  Lipid-bound sialic acid (LSA) in liver diseases of different etiologies.

Authors:  Lech Chrostek; Bogdan Cylwik; Anatol Panasiuk; Dorota Brodowska-Adamusiak; Ewa Gruszewska
Journal:  Ann Hepatol       Date:  2011 Apr-Jun       Impact factor: 2.400

9.  Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis.

Authors:  Fabio Dall'Olio; Mariella Chiricolo; Antonia D'Errico; Elisa Gruppioni; Annalisa Altimari; Michelangelo Fiorentino; Walter F Grigioni
Journal:  Glycobiology       Date:  2003-09-26       Impact factor: 4.313

10.  Serum sialic acid in malignant tumors, bacterial infections, and chronic liver diseases.

Authors:  N Stefenelli; H Klotz; A Engel; P Bauer
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

View more
  2 in total

1.  Fibrinogen measurement in liver disease: validation of the functional fibrinogen thromboelastography assay and a novel mathematical predictive model.

Authors:  Kirsty Rizzo; Kevin Vella; Daniel Zammit; Peter Gatt; Charlie Grima; Monique Borg Inguanez; Jurgen Gerada; Pierre Ellul; Mario Vassallo; Neville Azzopardi; James Pocock; Alex Gatt
Journal:  Blood Transfus       Date:  2018-11-09       Impact factor: 3.443

2.  Serum Sialic Acid Level Is Significantly Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: A Cross-Sectional Study.

Authors:  Zhenya Lu; Han Ma; Chengfu Xu; Zhou Shao; Chao Cen; Youming Li
Journal:  Biomed Res Int       Date:  2016-02-10       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.